CBD and Big Pharma

Where is “Big Pharma” on the CBD explosion? What products have been approved, in development and being considered? What are the benefits and down-falls of pharmaceutical cannabis? The world of “Big Pharma” is changing for the better. What’s happening now could be the best opportunity for the public to disrupt the pharmaceutical business by buying a product that they have already shown the world they want to buy from vendors. Hemp-derived CBD and Big Pharma are on a collision course and the consumer will be the winner. In this episode we discuss all these changes and the future of CBD and what it will mean to consumers. For more information on this topic, listen to this podcast and then check out this article or one of our previous podcasts about his topic.

About the Author
Ed Chaney is an experienced entrepreneur with over a dozen successful startups under his command. He has a passion for leadership and the ability to educate teams and audiences - qualities he acquired over the past 30 years. His affinity for positive company culture, team building, and leadership play a key role in his successful business-building endeavors. Mr. Chaney studied Business at Arizona State University, Executive Leadership at MIT, and spent over twenty years as an active member of Arizona’s elite Entrepreneur Organization (EO). As the host of the VoiceAmerica Podcast The CBD ED Show, Ed provides unbiased information so you can make informed decisions in the growing CBD market. With his regular co-host Kimberly Rose, Ed is joined by special guests and shares real-talk about CBD and the potential of this product.

Leave a Reply

Your email address will not be published.